...FDA’s advice. The analysis of NDAs and efficacy supplements filed between Jan. 1, 2008, and Dec...

...$15 million in Cytovia equity or in upfront cash if certain conditions aren’t met by Dec...

...the reported efficacy for the Russian vaccine was based on COVID-19 cases that occurred before Dec...

...of therapies for orphan and inflammatory disorders.Horizon had more than $2 billion in cash at Dec...

...STATUS: Patent and licensing status unavailablePUBLICATION DETAILS: Hait, A. et al. Sci. Immunol.; published online Dec...

...available for licensing or partneringPUBLICATION DETAILS: Ghosh, A. et al. Sci. Transl. Med.; published online Dec...

...culture; miceLICENSING STATUS: Unpatented; available for partneringPUBLICATION DETAILS: Shen, J. et al. Cell; published online Dec...

...STATUS: Patent and licensing status unavailablePUBLICATION DETAILS: Cao, Q. et al. Sci. Adv.; published online Dec...

...conditional approval for the AZ vaccine on Friday. The U.K., which authorized the AZ vaccine on Dec...

...some additional incumbency beyond a narrow first-mover advantage spanning about five weeks since that drug’s Dec...